Deep-Learning Models Can Predict Conversion to Normal-Tension Glaucoma
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, Nov. 3, 2023 -- Deep learning models trained with fundus images and clinical data can predict whether normotensive glaucoma suspect (GS) eyes will convert to normal-tension glaucoma (NTG), according to a study published online Nov. 2 in the British Journal of Ophthalmology.
Ahnul Ha, M.D., from Jeju National University in South Korea, and colleagues reviewed datasets of 12,458 GS eyes to assess performance of deep-learning models for prediction of conversion to NTG. A total of 210 eyes (105 eyes showing NTG conversion and 105 without conversion) were included and were followed up for a minimum of seven years or longer, during which time intraocular pressure (IOP) was lower than 21 mm Hg. The features of two fundus images were extracted; together with 15 clinical features, they were used to predict NTG conversion. Three machine learning classifiers (XGBoost, Random Forest, and Gradient Boosting) were used to perform prediction.
The researchers found that high diagnostic accuracy was achieved for NTG conversion prediction with all three algorithms. The areas under the curve varied from 0.987 (Random Forest trained with both fundus images and clinical features) to 0.994 (XGBoost trained with both fundus images and clinical features). For time to NTG conversion, the best prediction performance was seen for XGBoost (mean squared error, 2.24). For time-to-conversion prediction, the top three important clinical features were baseline IOP, diastolic blood pressure, and average circumpapillary retinal nerve fiber layer thickness.
"Our results suggest that deep learning models that have been trained on both ocular images and clinical data have a potential to predict disease progression in GS patients," the authors write.
Source: HealthDay
Posted : 2023-11-04 00:36
Read more
- Scientists Find Way to Deliver Medicines Across Brain's Protective Barrier
- Stroke Guidelines Updated, With Focus on Women and GLP-1s
- Mystery Illness Kills Dozens in Congo
- Bribing Kids With Holiday Gifts Popular With Parents, Poll Says
- Preferential Promotion of White Men Persisting in Academic Medicine
- Study Supports HPV Self-Testing for Cervical Cancer Screening
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions